Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Chemoinformatics Market

Chemoinformatics Market Share

Report ID: GMI9527
Published Date: May 2024
Report Format: PDF

Download Free Sample

Chemoinformatics Market Share

The chemoinformatics industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive software and services with improved accuracy and precision. This includes innovations such as automated workflow systems for workflow efficiency, reducing hands-on time, and reproducibility. Competition is driven by factors such as the quality and reliability of these technologies, integration capabilities with existing platforms, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Chemoinformatics Market Companies

Some of the eminent market participants operating in the chemoinformatics industry include:

ACD/Labs, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
BioSolveIT GmbH
Cadence Molecular Sciences LLC
Centara
ChemAxon Ltd
Chemical Computing Group ULC
Collaborative Drug Discovery Inc.
Dassault Systèmes
Jubilant Biosys Ltd
Molecular Discovery Ltd
OpenEye Scientific Software, Inc.
PerkinElmer Inc.
Schrödinger, Inc.
Scilligence

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Chemoinformatics market size was valued at USD 3.3 billion in 2023 and is estimated to grow at 15.5% CAGR from 2024 to 2032, owing to the advancements in computational technologies.

The software segment in the chemoinformatic market will generate USD 7 billion by 2032, as it provides essential tools for analyzing, managing, and visualizing chemical data, molecular structures, and biological activities.

U.S. chemoinformatics market is anticipated to grow at 15.1% CAGR during 2024-2032, attributed to the robust ecosystem for scientific R&D activities, with significant investments in both public and private sectors.

ACD/Labs, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSolveIT GmbH, Cadence Molecular Sciences LLC, Centara, ChemAxon Ltd, Chemical Computing Group ULC, Collaborative Drug Discovery Inc., and Dassault Syst